IAGL
VKTX icon

Innovative Advisory Group, LLC’s Viking Therapeutics VKTX Stock Holding History

Innovative Advisory Group, LLC’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-107
Closed -$3.76K – 221
2025
Q4 		$3.76K Hold
107
– – ﹤0.01% 175
2025
Q3 		$2.81K Hold
107
– – ﹤0.01% 184
2025
Q2 		$2.84K Hold
107
– – ﹤0.01% 177
2025
Q1 		$2.58K Hold
107
– – ﹤0.01% 157
2024
Q4 		$4.31K Buy
+107
New +$6.1K ﹤0.01% 132

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Innovative Advisory Group, LLC's VKTX Position: Q1 2026 in Review

Innovative Advisory Group, LLC sold out of Viking Therapeutics (VKTX) in Q1 2026, closing a stake of 107 shares — an estimated $3.76K sold.

Innovative Advisory Group, LLC first reported a position in VKTX in Q4 2024 and held it in 5 quarters. The position peaked at $4.31K in Q4 2024. 414 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Innovative Advisory Group, LLC reported no remaining Viking Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Innovative Advisory Group, LLC sold 107 Viking Therapeutics shares in Q1 2026, an estimated $3.76K.
  • Innovative Advisory Group, LLC first reported a position in Viking Therapeutics in Q4 2024 and held it in 5 quarters.
  • Innovative Advisory Group, LLC's Viking Therapeutics position peaked at $4.31K in Q4 2024.
  • 414 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Innovative Advisory Group, LLC's 13F filing for Q1 2026, filed 22 Sep 2026.